(Q37788679)

23 August 2017

title

Tumor infiltrating regulatory T cells: tractable targets for immunotherapy (English)

1 reference

23 August 2017

1 reference

Adnan R Khan

1

1 reference

23 August 2017

Simon J Dovedi

series ordinal

2

1 reference

23 August 2017

Robert W Wilkinson

series ordinal

3

1 reference

23 August 2017

David I Pritchard

series ordinal

4

1 reference

23 August 2017

publication date

1 October 2010

1 reference

International Reviews of Immunology

23 August 2017

published in

1 reference

23 August 2017

volume

29

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

461-484

1 reference

Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Adaptive immunity maintains occult cancer in an equilibrium state

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Transforming growth factors from a human tumor cell: characterization of transforming growth factor beta and identification of high molecular weight transforming growth factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

CD4 regulatory T cells in human cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Chemokine biology in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

The role of cytokines in classical Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Regulated production of the T helper 2-type T-cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Expression of macrophage-derived chemokine (MDC)/CCL22 in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Expression of CCL17 and CCL22 by latent membrane protein 1-positive tumor cells in age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Increases in serum TARC/CCL17 levels are associated with progression-free survival in advanced melanoma patients in response to dendritic cell-based immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Identification of the CC chemokines TARC and macrophage inflammatory protein-1 beta as novel functional ligands for the CCR8 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Inhibition of CCL1-CCR8 interaction prevents aggregation of macrophages and development of peritoneal adhesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Oestrogen receptor negative breast cancers exhibit high cytokine content

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

The interaction properties of costimulatory molecules revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

CTLA-4 control over Foxp3+ regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Modulation of tryptophan catabolism by regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

T cell apoptosis by tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Role of transcriptional repressor ICER in cyclic AMP-mediated attenuation of cytokine gene expression in human thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Human T regulatory cells can use the perforin pathway to cause autologous target cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Ovarian cancer creates a suppressive microenvironment to escape immune elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Cytokine regulation networks in the cancer microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Interleukin-2 is essential for CD4+CD25+ regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Signaling T-cell survival and death by IL-2 and IL-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Targeted knock down of CCL22 and CCL17 by siRNA during DC differentiation and maturation affects the recruitment of T subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

CCR4-expressing T cell tumors can be specifically controlled via delivery of toxins to chemokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia/lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

CCL2 blockade augments cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Recent developments in CCR2 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Chemokine receptor antagonists: overcoming developmental hurdles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Infliximab in the treatment of anti-CTLA4 antibody (ipilimumab) induced immune-related colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

A Phase II trial of Denileukin Diftitox in patients with previously treated advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Localized expression of GITR-L in the tumor microenvironment promotes CD8+ T cell dependent anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

GITR Blockade Facilitates Treg Mediated Allograft Survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

OX40 costimulation turns off Foxp3+ Tregs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Introduction of OX40 ligand into lymphoma cells elicits anti-lymphoma immunity in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Anti-OX40 monoclonal antibody therapy in combination with radiotherapy results in therapeutic antitumor immunity to murine lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Sunitinib efficacy against advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Sunitinib impairs the proliferation and function of human peripheral T cell and prevents T-cell-mediated immune response in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Imatinib mesylate inhibits CD4+ CD25+ regulatory T cell activity and enhances active immunotherapy against BCR-ABL- tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing V beta 8 TCR: a role of the Qa-1 molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

CD8+CD28- T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Critical role for CD8+FoxP3+ regulatory T cells in colon cancer immune response in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

CCR4-dependent regulatory T cell function in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Combined CXCR3/CCR5 blockade attenuates acute and chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Therapy for pneumonitis and sialadenitis by accumulation of CCR2-expressing CD4+CD25+ regulatory T cells in MRL/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

XCL1 enhances regulatory activities of CD4+ CD25(high) CD127(low/-) T cells in human allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

CXCR3 Signaling Reduces the Severity of Experimental Autoimmune Encephalomyelitis by Controlling the Parenchymal Distribution of Effector and Regulatory T Cells in the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

ICER/CREM-mediated transcriptional attenuation of IL-2 and its role in suppression by regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08830185.2010.508854

10.3109/08830185.2010.508854

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference